These outcomes, along with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,two aid the principle of concentrating on ACKR3 as a novel solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-simi